Lonza Group AG
name
Lonza Group AG
id
LONN
summary
Lonza Group is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Founded in 1897, Lonza provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector. The company has evolved from hydroelectricity and various chemical processes to become a leader in fine chemistry and biochemistry. Lonza is involved in the manufacturing of biologics with several pharmaceutical companies and has partnerships for the development and manufacturing of biosimilars and therapeutic monoclonal antibodies. As of 2023, Lonza employs over 17,500 people across about 35 countries.
industry
Pharmaceuticals, biotechnology
founded
1897
headquarters
Basel, Switzerland
key_people
Albert M. Baehny (Ad-interim CEO)
products
Biopharmaceuticals
revenue
CHF 4.508 billion (2021)
operating_income
CHF 1.665 billion (2021)
total_assets
CHF 16.459 billion (end 2021)
total_equity
CHF 9.823 billion (end 2021)
number_of_employees
17,500 (2023)
website
www.lonza.com